Results 261 to 270 of about 4,652,143 (319)
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura +19 more
wiley +1 more source
Protein-dependent CD4<sup>+</sup> T cell specialization and CD8<sup>+</sup> T cell-driven IL-2 production in HIV. [PDF]
Pušnik J +5 more
europepmc +1 more source
Alternatively activated neutrophils limit T cell-driven neuroinflammation. [PDF]
Atkinson JR +13 more
europepmc +1 more source
CAR-T cell immunotherapy in rhabdomyosarcoma. [PDF]
Safarzadeh Kozani P +2 more
europepmc +1 more source
Mechanistic basis and therapeutic modulation of T cell fitness to enhance CAR-T cell efficacy in hematological malignancies. [PDF]
Makni-Maalej K +12 more
europepmc +1 more source
Enable CAR T cell immunotherapy in glioblastoma by modifying its microenvironment via oncolytic adenovirus encoding bispecific T cell engager. [PDF]
Choi MJ +9 more
europepmc +1 more source

